Group One Trading’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-8,400
| Closed | -$30.1K | – | 8325 |
|
|
2026
Q1 | $30.1K | Buy |
8,400
+6,800
| +425% | +$27K | ﹤0.01% | 5668 |
|
|
2025
Q4 | $5.62K | Sell |
1,600
-6,000
| -79% | -$20.5K | ﹤0.01% | 7130 |
|
|
2025
Q3 | $24.8K | Buy |
7,600
+4,200
| +124% | +$13.2K | ﹤0.01% | 6534 |
|
|
2025
Q2 | $8.33K | Sell |
3,400
-18,700
| -85% | -$94.7K | ﹤0.01% | 6828 |
|
|
2025
Q1 | $147K | Buy |
22,100
+14,100
| +176% | +$139K | ﹤0.01% | 4266 |
|
|
2024
Q4 | $101K | Buy |
8,000
+5,900
| +281% | +$88.8K | ﹤0.01% | 4516 |
|
|
2024
Q3 | $38.8K | Sell |
2,100
-16,400
| -89% | -$336K | ﹤0.01% | 4815 |
|
|
2024
Q2 | $398K | Buy |
18,500
+11,700
| +172% | +$269K | ﹤0.01% | 2771 |
|
|
2024
Q1 | $183K | Sell |
6,800
-20,900
| -75% | -$594K | ﹤0.01% | 3632 |
|
|
2023
Q4 | $830K | Buy |
27,700
+26,600
| +2,418% | +$587K | ﹤0.01% | 2635 |
|
|
2023
Q3 | $22.5K | Buy |
1,100
+600
| +120% | +$10.9K | ﹤0.01% | 5799 |
|
|
2023
Q2 | $9.94K | Buy |
500
+300
| +150% | +$6.06K | ﹤0.01% | 6398 |
|
|
2023
Q1 | $3.43K | Buy |
200
+100
| +100% | +$1.96K | ﹤0.01% | 6443 |
|
|
2022
Q4 | $1.96K | Buy |
+100
| New | +$1.84K | ﹤0.01% | 6662 |
|
|
2022
Q1 | – | Sell |
-100
| Closed | -$2K | – | 8569 |
|
|
2021
Q4 | $2K | Buy |
+100
| New | +$2.73K | ﹤0.01% | 7899 |
|
|
2021
Q3 | – | Sell |
-10,800
| Closed | -$478K | – | 8681 |
|
|
2021
Q2 | $478K | Sell |
10,800
-9,400
| -47% | -$408K | ﹤0.01% | 4265 |
|
|
2021
Q1 | $896K | Buy |
20,200
+9,000
| +80% | +$494K | ﹤0.01% | 3364 |
|
|
2020
Q4 | $614K | Buy |
11,200
+6,900
| +160% | +$252K | ﹤0.01% | 3092 |
|
|
2020
Q3 | $98K | Buy |
+4,300
| New | +$106K | ﹤0.01% | 4207 |
|
|
2020
Q1 | – | Sell |
-6,000
| Closed | -$137K | – | 5661 |
|
|
2019
Q4 | $137K | Buy |
+6,000
| New | +$100K | ﹤0.01% | 3441 |
|
|
2018
Q1 | – | Sell |
-2,250
| Closed | -$23K | – | 5229 |
|
|
2017
Q4 | $23K | Buy |
+2,250
| New | +$22.3K | ﹤0.01% | 4102 |
|
|
2017
Q3 | – | Sell |
-3,750
| Closed | -$29K | – | 5094 |
|
|
2017
Q2 | $29K | Sell |
3,750
-250
| -6% | -$1.86K | ﹤0.01% | 3799 |
|
|
2017
Q1 | $32K | Sell |
4,000
-1,700
| -30% | -$11.4K | ﹤0.01% | 3655 |
|
|
2016
Q4 | $139K | Buy |
5,700
+5,675
| +22,700% | +$162K | ﹤0.01% | 2651 |
|
|
2016
Q3 | $1K | Hold |
25
| – | – | ﹤0.01% | 4448 |
|
|
2016
Q2 | $1K | Hold |
25
| – | – | ﹤0.01% | 4517 |
|
|
2016
Q1 | $1K | Buy |
+25
| New | +$750 | ﹤0.01% | 4448 |
|
Other funds holding RCKT
RI
NM
MC
Group One Trading's RCKT Position: Q2 2026 in Review
Group One Trading sold out of Rocket Pharmaceuticals (RCKT) in Q2 2026, closing a stake of 57,382 shares — an estimated $191K sold.
Group One Trading first reported a position in RCKT in Q3 2016 and held it in 19 quarters. The position peaked at $205K in Q1 2026. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.
- Group One Trading reported no remaining Rocket Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Group One Trading sold 57,382 Rocket Pharmaceuticals shares in Q2 2026, an estimated $191K.
- Group One Trading first reported a position in Rocket Pharmaceuticals in Q3 2016 and held it in 19 quarters.
- Group One Trading's Rocket Pharmaceuticals position peaked at $205K in Q1 2026.
- 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.